AS Latvijas Juras medicinas centrs (RSE:LJM1R)
Latvia · Delayed Price · Currency is EUR 7.80
-0.05 (-0.64%)
Inactive · Last trade price on Mar 9, 2026
RSE:LJM1R Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Market Capitalization | 6 | 7 | 5 | 8 | 10 | 10 |
Market Cap Growth | 19.35% | 30.88% | -35.85% | -10.92% | -6.30% | 70.47% |
Enterprise Value | 5 | 6 | 5 | 8 | 9 | 8 |
Last Close Price | 7.80 | 8.90 | 6.40 | 9.80 | 11.40 | 12.30 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.56 | 29.54 | 30.53 | - | 15.21 | 11.54 |
PS Ratio | 0.58 | 0.69 | 0.53 | 0.86 | 0.98 | 1.09 |
PB Ratio | 0.94 | 1.13 | 0.85 | 1.37 | 1.40 | 1.60 |
P/TBV Ratio | 0.94 | 1.13 | 0.85 | 1.37 | 1.40 | 1.60 |
P/FCF Ratio | 15.24 | 18.33 | 28.76 | - | 20.51 | - |
P/OCF Ratio | 10.22 | 12.29 | 8.70 | 4.43 | 7.28 | 24.29 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.46 | 0.60 | 0.45 | 0.79 | 0.88 | 0.91 |
EV/EBITDA Ratio | 5.38 | 7.04 | 5.77 | 16.32 | 8.09 | 7.27 |
EV/EBIT Ratio | 18.46 | 23.98 | 25.89 | - | 13.61 | 9.63 |
EV/FCF Ratio | 12.27 | 15.94 | 24.39 | - | 18.36 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Debt / Equity Ratio | -0.18 | -0.18 | -0.13 | -0.11 | -0.19 | -0.16 |
Net Debt / EBITDA Ratio | -1.31 | -1.31 | -1.08 | -1.41 | -1.25 | -0.87 |
Net Debt / FCF Ratio | -2.97 | -2.97 | -4.57 | 1.19 | -2.85 | 1.47 |
Asset Turnover | 1.16 | 1.16 | 1.13 | 1.10 | 1.13 | 1.20 |
Inventory Turnover | 72.58 | 72.58 | 64.13 | 59.59 | 56.93 | 52.64 |
Quick Ratio | 0.78 | 0.78 | 0.68 | 0.59 | 1.21 | 1.23 |
Current Ratio | 0.86 | 0.86 | 0.76 | 0.68 | 1.69 | 1.80 |
Return on Equity (ROE) | 3.79% | 3.79% | 2.83% | -9.60% | 9.52% | 14.85% |
Return on Assets (ROA) | 1.81% | 1.81% | 1.23% | -0.51% | 4.58% | 7.06% |
Return on Invested Capital (ROIC) | 4.56% | 4.51% | 3.23% | -1.32% | 11.58% | 19.40% |
Return on Capital Employed (ROCE) | 3.70% | 3.70% | 2.50% | -1.00% | 8.50% | 12.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.07% | 3.38% | 3.28% | -7.36% | 6.57% | 8.66% |
FCF Yield | 6.56% | 5.46% | 3.48% | -6.68% | 4.88% | -6.81% |
Dividend Yield | 1.27% | - | 1.56% | - | - | 1.63% |
Payout Ratio | 33.20% | 33.20% | - | - | 25.57% | 6.36% |
Total Shareholder Return | 1.27% | - | 1.56% | - | - | 1.63% |